论文部分内容阅读
目的探讨血液透析与血液灌流联合治疗对长期血液透析患者微炎性因子和钙磷代谢的作用。方法选取2015年1月~2017年2月我院收治的82例长期血液透析患者,随机分为对照组与研究组,各41例。对照组给予血液透析治疗,研究组给予血液透析与血液灌流联合治疗,比较两组的微炎性因子和钙磷代谢水平。结果,研究组治疗后的微炎性因子指标(hs-CRP、Hb、Alb、TC)及钙磷代谢水平(血钙、血磷)均明显得到改善,且优于对照组,差异有统计学意义(P<0.05)。结论血液透析与血液灌流联合治疗对长期血液透析患者微炎性因子和钙磷代谢的改善有积极作用,值得临床推广。
Objective To investigate the effect of hemodialysis and hemoperfusion on the micro-inflammatory factor and calcium-phosphorus metabolism in patients with chronic hemodialysis. Methods 82 long-term hemodialysis patients admitted to our hospital from January 2015 to February 2017 were randomly divided into control group and study group, 41 cases in each group. The control group was given hemodialysis. The study group was given hemodialysis and hemoperfusion combined therapy. The micro-inflammatory factors and calcium and phosphorus metabolism were compared between the two groups. Results After treatment, the microinflammatory factors (hs-CRP, Hb, Alb, TC) and the levels of calcium and phosphorus metabolism (serum calcium and phosphorus) in the study group were significantly improved and better than those in the control group Significance (P <0.05). Conclusion The combination of hemodialysis and hemoperfusion has a positive effect on the improvement of the micro-inflammatory factor and the metabolism of calcium and phosphorus in long-term hemodialysis patients, which is worthy of clinical promotion.